Innovations in Microbial  Biotechnologies

ABOUT US

AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

We focus on developing novel technologies for improved production in Microbial Biosynthetic Factories. Our technologies have the potential for a multi-fold increase in yields of biosynthetic processes.

Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. 

The core technical idea comes as a spin-off of the academic project, previously conducted at the University of Wyoming, USA. Unlike traditional biotechnological approaches, our innovation is based on programmed differentiation of diverse cell types within the microbial population. This differentiation is a function of induced asymmetric cell division. 

Our ability to control asymmetry and differentiation of microbial cells results in the presence of Regenerative "Stem Cells", supporting the emergence of new "Factory Cells", which are responsible for the biosynthesis of a target product. We called this approach "Microbial Stem Cell Technology" (MiST)

Applications of MiST for the production of biopharmaceuticals, biofuels, and materials is the main goals of AsimicA.

 
 

What We Do

AsimicA was launched in November 2018, by Nikolai Mushnikov and Grant Bowman.

We focus on developing novel technologies for improved production in Microbial Biosynthetic Factories. Our technologies have the potential for a multi-fold increase in yields of biosynthetic processes.

Since relatively low yields of target products, made through the biosynthesis is the major limitation of biotechnology, our innovative approaches for production may revolutionize the industry. 

The core technical idea comes as a spin-off of the academic project, previously conducted at the University of Wyoming, USA. Unlike traditional biotechnological approaches, our innovation is based on programmed differentiation of diverse cell types within the microbial population. This differentiation is a function of induced asymmetric cell division. 

Our ability to control asymmetry and differentiation of microbial cells results in the presence of Regenerative "Stem Cells", supporting the emergence of new "Factory Cells", which are responsible for the biosynthesis of a target product. We called this approach "Microbial Stem Cell Technology" (MiST)

Applications of MiST for the production of biopharmaceuticals, biofuels, and materials is the main goals of AsimicA.

CONTACT US

Laramie Wyoming

email: info@asimica.com

 
 

© 2020 by AsimicA